glp-1 controversy Hims & Hers, and the Brewing Compounding Controversy surrounding diabetes drug, Ozempic,

In this review, the occurrence and toxicological features of major Aspergillus -derived mycotoxins are summarized and, furthermore, the possibilities of treatments in the medical practice to heal the deleterious consequences of acute and/or chronic exposures are presented

Prog Brain Res 1998

Status of GLP-1RA drug in developing MASLD indication Generally, targeted drugs include single GLP-1R agonists and co-agonists, as well as combination formulations, innovative oral peptide preparations, and non-peptide small molecule agonists

Lancet 392 , 21802193 (2018) D

Also, showing a survival advantage with pembrolizumab encourages developers to evaluate broader use of immunotherapy in PROC